Immune activation, inflammation and HIV DNA after 96 weeks of ATV/r monotherapy: a MODAt substudy

E Merlini, L Galli, C Tincati, ES Cannizzo, A Galli, N Gianotti, G Ancona, C Muccini, A D'Arminio Monforte, G Marchetti, A Castagna, the MODAt study group

Research output: Contribution to journalArticle

Abstract

No abstract available
Original languageEnglish
Pages (from-to)633-637
Number of pages5
JournalAntiviral Therapy
Volume23
Issue number7
DOIs
Publication statusPublished - 2018

Fingerprint Dive into the research topics of 'Immune activation, inflammation and HIV DNA after 96 weeks of ATV/r monotherapy: a MODAt substudy'. Together they form a unique fingerprint.

  • Cite this

    Merlini, E., Galli, L., Tincati, C., Cannizzo, ES., Galli, A., Gianotti, N., Ancona, G., Muccini, C., D'Arminio Monforte, A., Marchetti, G., Castagna, A., & group, T. MODA. S. (2018). Immune activation, inflammation and HIV DNA after 96 weeks of ATV/r monotherapy: a MODAt substudy. Antiviral Therapy, 23(7), 633-637. https://doi.org/10.3851/IMP3234